Charlier, Bruno
 Distribuzione geografica
Continente #
AS - Asia 3.004
NA - Nord America 1.162
EU - Europa 653
SA - Sud America 149
AF - Africa 24
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.001
Nazione #
HK - Hong Kong 2.258
US - Stati Uniti d'America 1.128
SG - Singapore 354
IT - Italia 255
CN - Cina 135
RU - Federazione Russa 127
VN - Vietnam 110
BR - Brasile 100
DE - Germania 61
FR - Francia 50
GB - Regno Unito 41
IN - India 37
IE - Irlanda 20
FI - Finlandia 18
AR - Argentina 17
KR - Corea 17
PL - Polonia 17
CA - Canada 15
MX - Messico 15
BD - Bangladesh 14
SE - Svezia 13
ES - Italia 12
JP - Giappone 11
EC - Ecuador 10
IQ - Iraq 10
NL - Olanda 10
TR - Turchia 9
AT - Austria 8
AU - Australia 8
PK - Pakistan 8
SA - Arabia Saudita 8
UA - Ucraina 8
ZA - Sudafrica 7
UY - Uruguay 5
CO - Colombia 4
EG - Egitto 4
ID - Indonesia 4
KE - Kenya 4
SY - Repubblica araba siriana 4
JO - Giordania 3
LB - Libano 3
MY - Malesia 3
PY - Paraguay 3
VE - Venezuela 3
CL - Cile 2
DZ - Algeria 2
GY - Guiana 2
LT - Lituania 2
MA - Marocco 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ET - Etiopia 1
GP - Guadalupe 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
MM - Myanmar 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
TZ - Tanzania 1
Totale 5.001
Città #
Hong Kong 2.251
Singapore 192
San Jose 181
Dallas 152
Ashburn 108
Chandler 93
Princeton 50
Munich 47
Ann Arbor 45
Naples 45
Council Bluffs 39
Beijing 33
Ho Chi Minh City 33
Los Angeles 32
New York 30
Lauterbourg 27
Hanoi 22
Dublin 20
Dong Ket 17
Rome 17
Salerno 17
The Dalles 17
Woodbridge 15
Moscow 14
Redwood City 14
São Paulo 14
Warsaw 14
Jacksonville 13
Mercato San Severino 13
Pune 13
Turku 13
Wokingham 13
Orem 12
Santa Clara 12
Stockholm 12
Fisciano 11
Seattle 10
Chennai 8
Tokyo 8
Wilmington 8
Amsterdam 7
Houston 7
London 7
Arba 6
Brooklyn 6
Montpellier 6
Montreal 6
San Prisco 6
Adelaide 5
Denver 5
Francavilla Fontana 5
Guangzhou 5
Haiphong 5
Izmir 5
Johannesburg 5
Milan 5
Montevideo 5
Nuremberg 5
Palermo 5
Phoenix 5
Seoul 5
Tianjin 5
Valencia 5
Andover 4
Aversa 4
Boardman 4
Brasília 4
Chicago 4
Glasgow 4
Guayaquil 4
Mexico City 4
Nairobi 4
Norwalk 4
Ottawa 4
Quito 4
Rio de Janeiro 4
San Francisco 4
Verona 4
Atlanta 3
Biên Hòa 3
Bologna 3
Caserta 3
Fairfield 3
Hebei 3
Helsinki 3
Jakarta 3
Manchester 3
Medina 3
Mumbai 3
Nanchang 3
Nanjing 3
Napoli 3
Novate Milanese 3
Poplar 3
Richmond 3
Toronto 3
Washington 3
Abha 2
Asunción 2
Belo Horizonte 2
Totale 3.934
Nome #
A UHPLC-MS/MS-based method for the simultaneous monitoring of eight antiblastic drugs in plasma and urine of exposed healthcare workers 783
Development and Validation of a Reverse-Phase High-Performance Liquid Chromatography with Fluorescence Detection (RP-HPLC-FL) Method to Quantify Ruxolitinib in Plasma Samples 580
Antioxidant Supplementation Hinders the Role of Exercise Training as a Natural Activator of SIRT1 421
Effects of selected preanalytical variables on Dried Blood Spot (DBS) and Volumetric Adsorptive Microsampling (VAMS) based bioanalytical methods for the determination of four β-lactam antibiotics 248
Come rendere un ospedale formaldeide free 227
In Vitro Evaluation of Antibacterial and Antibiofilm Activity of Different Chlorhexidine-Containing Mouthwash Formulations against Streptococcus mutans 216
Standard addition method (SAM) in LC-MS/MS to quantify gluten-derived metabolites in urine samples 192
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 189
A genotyping/phenotyping approach with careful clinical monitoring to manage the fluoropyrimidines-based therapy: Clinical cases and systematic review of the literature 182
Chemical risk in hospital settings: Overview on monitoring strategies and international regulatory aspects 140
Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease 131
Development and Validation of a New LC-MS/MS Bioanalytical Method for the Simultaneous Determination of Levodopa, Levodopa Methyl Ester, and Carbidopa in Human Plasma Samples 126
Development and Validation of a UHPLC–MS/MS-Based Method to Quantify Cenobamate in Human Plasma Samples 121
Development of a novel ion-pairing HPLC-FL method for the separation and quantification of hydroxychloroquine and its metabolites in whole blood 118
Therapeutic drug monitoring might identify poor responders to ruxolitinib treatment in myeloproliferative neoplasms 118
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 116
BONE MARROW MESENCHYMAL STEM CELLS AS FACILITATOR OF RUXOLITINIB-MEDIATED INHIBITION OF JAK2 MUTADED CELLS 114
Novel Drug Targets for the Treatment of Cardiac Diseases 113
Environmental and biological monitoring of formaldehyde inside a hospital setting: a combined approach to manage chemical risk in workplaces 110
Perampanel dosage in plasma samples: development and validation of a novel HPLC method with combined UV-Fluorescence detection 108
A LC-MS/MS based methodology for the environmental monitoring of healthcare settings contaminated with antineoplastic agents 101
The Effect of Plasma Protein Binding on the Therapeutic Monitoring of Antiseizure Medications 91
Lipid nano-vesicles for thyroid hormone encapsulation: A comparison between different fabrication technologies, drug loading, and an in vitro delivery to human tendon stem/progenitor cells in 2D and 3D culture 89
Bioconversion of 4-hydroxyestradiol by extradiol ring-cleavage dioxygenases from Novosphingobium sp. PP1Y 88
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson's Disease 86
Pharmacological Treatments and Therapeutic Drug Monitoring in Patients with Chronic Pain 72
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial 54
Quantitative Analysis of Cenobamate and Concomitant Anti-Seizure Medications in Human Plasma via Ultra-High Performance Liquid Chromatography–Tandem Mass Spectrometry 51
Clinical predictors and concomitant antiseizure medications effects on seizure control in relation to plasma cenobamate concentration: a multicenter retrospective study 38
Do Cenobamate Pharmacokinetics Change with Co-Administered Antiseizure Medications? An Exploratory Analysis of Responder Patients with Focal Drug-Resistant Epilepsy 25
Long-Term Impact of Cenobamate on Cognition, Adaptive Behavior, and Quality of Life in Patients with Tuberous Sclerosis Complex 15
Totale 5.063
Categoria #
all - tutte 13.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.728


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202161 0 0 0 0 0 0 0 0 0 25 10 26
2021/202297 1 12 0 3 6 5 3 6 5 6 12 38
2022/2023249 15 33 37 32 17 40 6 18 30 0 6 15
2023/2024191 20 17 9 13 23 38 11 12 4 8 15 21
2024/2025536 4 12 9 16 37 42 121 30 77 23 67 98
2025/20263.699 138 1.359 1.036 185 233 74 236 77 145 216 0 0
Totale 5.063